Pfizer finally abandons dementia drug trials
LONDON: Pharmaceutical giant Pfizer says it will stop looking for new Alzheimer’s drugs, implicitly accepting… read more
Bad week for dementia R&D after Axovant howler & another failed trial
BERNE: A bad week for dementia research just got worse after Axovant embarrassingly admitted it… read more



















